See. Understand. Treat.
We develop medical imaging solutions to improve treatment effectiveness using state-of-the-art technology, software analysis tools and big data. Our research activities bridge the stage of early development all the way into clinical practice.
In our BRIDGE research programme, we bring together clinical imaging experts, IT experts, imaging methodology experts, basic scientists and clinicians. Together we see, understand and treat.
Personalized medicine has become the cornerstone in the medical community by optimizing treatment for each patient. Our advanced medical imaging solutions not only contribute to the improved treatment of oncological diseases, but are also increasingly important in the fields of infection and inflammation, cardiology and neurology.
We use medical imaging in prevention, early detection, staging, and therapy, thus helping clinicians select the best treatment for the individual patient. Within BRIDGE we bring together all the people in this field, from basic scientists to methodological experts, translational experts, imaging specialists and clinicians. Jointly we develop innovative biomarkers and techniques, all with just one aim: helping our patients.
To translate and implement new imaging biomarkers, we need to demonstrate their mechanism, assess their performance and robustness, determine the optimal way of data collection and assess its clinical value.
With our research, we standardize, validate, calibrate and test measurement methods to guarantee reproducibility and result robustness.
Imaging has become an integral part of the work-up in patient care and therapy. This ranges from diagnosis, treatment prediction, selection and planning, response monitoring and the assessment of tissue damage. We use imaging to help identify patients that may more likely benefit from complex treatments, thereby avoiding unnecessary or inappropriate treatments.
